Cargando…
Efficiency of Cell Therapy to GC-Induced ONFH: BMSCs with Dkk-1 Interference Is Not Superior to Unmodified BMSCs
Glucocorticoid-induced osteonecrosis of the femoral head (ONFH) is a hip disorder, and it threatens patients who require megadose of steroid therapies. Nowadays, no valid therapies can reverse the development of GC-induced ONFH once it occurs. Stem cell therapy to GC-induced ONFH would be a promisin...
Autores principales: | Zhun, Wei, Donghai, Li, Zhouyuan, Yang, Haiyan, Zhao, Pengde, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987233/ https://www.ncbi.nlm.nih.gov/pubmed/29951100 http://dx.doi.org/10.1155/2018/1340252 |
Ejemplares similares
-
CircHGF suppressed cell proliferation and osteogenic differentiation of BMSCs in ONFH via inhibiting miR-25-3p binding to SMAD7
por: Feng, Xiaobo, et al.
Publicado: (2022) -
Glucocorticoids decreased Cx43 expression in osteonecrosis of femoral head: The effect on proliferation and osteogenic differentiation of rat BMSCs
por: Zhao, Xin, et al.
Publicado: (2020) -
Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials
por: Li, Donghai, et al.
Publicado: (2018) -
miR-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration via Repressing Dkk3
por: Zhao, Changming, et al.
Publicado: (2021) -
Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs
por: Wang, Chenglong, et al.
Publicado: (2022)